Data / Form D filings / Alveus Therapeutics, Inc.
Alveus Therapeutics, Inc.: Form D filing
Alveus Therapeutics, Inc., a pharmaceuticals company in Philadelphia, PA, filed a Form D with the SEC in 2026. The latest, on January 14, 2026, reports $56.9 million sold of a $110.7 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 N. 18TH STREET, SUITE 1930, Philadelphia, PA, 19103
- Phone
- (215) 419-7830
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2075856
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 14, 2026 | New notice | $110,724,980 | $56,862,480 | $53,862,500 | 17 | Dec 22, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gregory Parekh | Director | |
| Ivan Gergel | Director | |
| Garrett Ingram | Director | |
| Carlo de Notaristefani | Director | |
| Ameet Nathwani | Director | |
| Raj Kannan | Executive Officer, Director | |
| Jan Van de Bossche | Director | |
| Claudio Nessi | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
- PLEOPHARMA, INC. $5.5 million · Aug 10, 2026
- Duo Oncology Inc. $1.6 million · Aug 7, 2026
Every Form D from the week of Jan 12, 2026 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Alveus Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.